CITF Research Results

CITF Research Results2023-10-27T10:53:53-04:00

Vaccine-induced seroprevalence hits highest level to date, yet early fourth wave hitting those most at-risk: Canadian Blood Services August report

96% of Canadian blood donors have evidence of SARS-CoV-2 antibodies, primarily due to vaccination, a rate that has increased from 91% in June and 95% in July. This according to Canadian Blood Services’ 13th seroprevalence report, covering data from August 2021. Nonetheless, targeted efforts to alleviate infection burden and promote vaccine uptake are still required amongst racialized donors and those living in lower-income neighbourhoods, [...]

November 19, 2021|General population studies|

Incarcerated individuals face an increased risk of acquiring COVID-19

Congregate settings (such as prisons, long-term care homes) have provided opportunities for COVID-19 to flourish. As part of her CITF-funded work recently released in a Lancet preprint, therefore not yet peer reviewed, Dr. Nadine Kronfli from the Research Institute of the McGill University Health Centre found that the number of incarcerated men at three provincial prisons in Quebec with antibodies due to a SARS-CoV-2 infection was two times higher than among nonvaccinated individuals in the Montreal area.

November 12, 2021|Geographic & priority populations|

A Canadian platform to study the antibody response to SARS-CoV-2 infection and vaccination

In a paper now published in Clinical and Translational Immunology, a team of Canadian researchers partly funded by the CITF and led by Drs. Anne-Claude Gingras from Toronto’s Lunenfeld-Tanenbaum Research Institute, Marc-André Langlois from the University of Ottawa, and Yves Durocher from the National Research Council of Canada, has developed a set of standardized, high-throughput serological assays to detect antibodies against SARS-CoV-2.

October 29, 2021|Optimization of immunologic testing|
Go to Top